Marvell-Lumentum All-Stock Merger Draws Backlash From Both Shareholder Bases
Investors in both Marvell and Lumentum pushed back sharply against the proposed all-stock acquisition, sending shares of each company lower Monday.
Shareholders on both sides of a proposed merger deal are voicing rare unified opposition after Marvell Technology announced an all-stock agreement to acquire optical components maker Lumentum, with critics wasting little time labeling the offer inadequate.
Shares of both Marvell and Lumentum declined Monday following the announcement, a market signal that investors were skeptical of the deal's terms and strategic rationale. The simultaneous selloff in acquirer and target alike is an unusual dynamic that underscores the breadth of dissatisfaction with the transaction's structure.
Read more Otter Tail Corp Misses Earnings and Revenue Estimates in Latest Quarter →
All-stock deals place the burden of risk squarely on shareholders of both companies, tying the value of any payout to future stock performance rather than a fixed cash price. That structure can draw criticism when either company's valuation is considered stretched or when the exchange ratio is seen as unfavorable — concerns that appear to be driving the current pushback from Lumentum holders who view the offer as undervaluing their shares.
The deal, if completed, would expand Marvell's footprint in photonics and optical networking components, sectors experiencing growing demand tied to artificial intelligence data center infrastructure buildouts. Analysts have noted that strategic logic may exist for the combination over the long term, but near-term shareholder sentiment appears firmly skeptical of whether the premium — or lack thereof — justifies the transaction.
Continue reading at MarketWatch.com
